Aktana, the leader in intelligent customer engagement for the global life sciences industry, today announced Contextual Intelligence 360, a new, modular solution that enables commercial teams to rapidly scale AI-driven programs that personalize the customer experience, coordinate engagement and optimize the entire customer journey across channels.
Aktana, the leader in intelligent customer engagement for the global life sciences industry, today announced its Contextual Intelligence Engine (CIE) 2.0. The upgraded version of the CIE is designed specifically for two of the most urgent needs in life sciences commercial operations today: omnichannel optimization and AI flexibility. Contextual Intelligence Engine 2.0 can work with any number …
1315 Capital, a Philadelphia-based healthcare growth equity firm investing in commercial stage companies across healthcare services, medical devices, and therapeutics / pharmaceutical services, has acquired a majority interest in Homestead Smart Health Plans (“Homestead”), one of the fastest-growing organizations in the reference-based pricing solutions market. Homestead enables employers to operate as self-funded and save significant healthcare …
Onkos Surgical, a leading innovator of solutions for musculoskeletal oncology and complex orthopaedic procedures, today announced that it has raised $15 million in Series C funding from its existing investor syndicate.
Real Chemistry, a global health innovation company, and Aktana, the leader in intelligent customer engagement for the global life sciences industry, today announced a partnership that will transform commercial strategy, engagement and execution. Pre-built integrations between the two companies’ solutions will translate Real Chemistry’s billions of healthcare social data points from 3 million healthcare influencers and 160,000 …
Misonix, Inc. (Nasdaq: MSON) (“Misonix” or the “Company”), a provider of minimally invasive therapeutic ultrasonic medical devices and regenerative products that enhance clinical outcomes today announced preliminary unaudited fiscal 2021 fourth quarter and full year revenue results for the three- and twelve-month periods ended June 30, 2021. In a separate statement issued together with Bioventus, Inc. (Nasdaq: BVS) (“Bioventus”), Misonix announced …
QIAGEN N.V. (NYSE: QGEN) (Frankfurt Prime Standard: QIA) and Verogen Inc. today announced a partnership to provide laboratories with superior tools and comprehensive support for implementing next-generation sequencing (NGS) human identification workflows.
Onkos Surgical, a leading innovator of solutions for musculoskeletal oncology and complex orthopaedic procedures, today announced that it has received FDA 510(k) clearance for its modular collar portfolio featuring the Company’s BioGrip® 3D-printed implant technology. The patented design, now available as part of the ELEOSTM Limb Salvage System, was created to help address the clinical challenge of aseptic loosening (also …
Sientra, Inc. (NASDAQ: SIEN) (“Sientra” or the “Company”), a medical aesthetics company uniquely focused on plastic surgeons, today announced it has closed the previously announced sale of its miraDry business to 1315 Capital, a healthcare growth equity firm investing in commercial stage companies across medical devices, healthcare services, and therapeutics. The transaction was previously described in …
Aktana, the global leader in intelligent customer engagement for the life sciences industry, announced a strategic investment in its mission to elevate the omnichannel experience for healthcare professionals (HCPs) with its appointment of Bingqian Gao as senior director of global advanced analytics. Prior to Aktana, Bingqian led the data science team at TrueCue, an analytics …
Colorescience®, a leading dermatologist-recommended skincare company, is pleased to announce the launch of two new additions to its award-winning Total Protection™ Face Shield line of all-mineral sunscreens. New Face Shield Flex SPF 50 ($45) and Face Shield Matte SPF 50 ($39) feature the brand’s proprietary EnviroScreen® Technology to provide comprehensive protection from environmental aggressors.
Sientra, Inc. (NASDAQ: SIEN) (“Sientra” or the “Company”), a medical aesthetics company uniquely focused on plastic surgeons, today announced it has entered into a definitive agreement to sell its miraDry business to 1315 Capital, a healthcare growth equity firm investing in commercial stage companies across medical devices, healthcare services, and therapeutics. Subject to certain terms and …